Skip Nav Destination
Issues
15 April 2018
-
Cover Image
Cover Image
The cover shows a mixed urothelial and small cell carcinoma from a single patient. Deep sequencing of macrodissected urothelial and small-cell components revealed truncal mutations clonal in both components, indicating a common ancestral origin. Other driver mutations were clonal exclusively in one component. For details, see the article by Chang and colleagues on page 1965 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
Editorial
CCR Translations
CCR Perspectives in Regulatory Science and Policy
Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections
Janice Kim; Harpreet Singh; Kassa Ayalew; Kristina Borror; Michelle Campbell; Laura Lee Johnson; Alyson Karesh; Ni A. Khin; Joanne R. Less; Jerry Menikoff; Lori Minasian; Sandra A. Mitchell; Elektra J. Papadopoulos; Richard L. Piekarz; Kevin A. Prohaska; Susan Thompson; Rajeshwari Sridhara; Richard Pazdur; Paul G. Kluetz
Review
Perspectives
Cancer Therapy: Clinical
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Michael B. Atkins; F. Stephen Hodi; John A. Thompson; David F. McDermott; Wen-Jen Hwu; Donald P. Lawrence; Nancy A. Dawson; Deborah J. Wong; Shailender Bhatia; Marihella James; Lokesh Jain; Seth Robey; Xinxin Shu; Blanca Homet Moreno; Rodolfo F. Perini; Toni K. Choueiri; Antoni Ribas
Author Choice
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
Neil H. Segal; Aiwu R. He; Toshihiko Doi; Ronald Levy; Shailender Bhatia; Michael J. Pishvaian; Rossano Cesari; Ying Chen; Craig B. Davis; Bo Huang; Aron D. Thall; Ajay K. Gopal
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
Yu-Pei Chen; Ling-Long Tang; Qi Yang; Sharon-Shuxian Poh; Edwin P. Hui; Anthony T.C. Chan; Whee-Sze Ong; Terence Tan; Joseph Wee; Wen-Fei Li; Lei Chen; Brigette B.Y. Ma; Macy Tong; Sze-Huey Tan; Shie-Lee Cheah; Kam-Weng Fong; Kiattisa Sommat; Yoke Lim Soong; Ying Guo; Ai-Hua Lin; Ying Sun; Ming-Huang Hong; Su-Mei Cao; Ming-Yuan Chen; Jun Ma
Author Choice
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Björklund; Mattias Carlsten; Ebba Sohlberg; Lisa L. Liu; Trevor Clancy; Mohsen Karimi; Sarah Cooley; Jeffrey S. Miller; Monika Klimkowska; Marie Schaffer; Emma Watz; Kristina Wikström; Pontus Blomberg; Björn Engelbrekt Wahlin; Marzia Palma; Lotta Hansson; Per Ljungman; Eva Hellström-Lindberg; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Isabel Echavarria; Sara López-Tarruella; Antoni Picornell; Jose Ángel García-Saenz; Yolanda Jerez; Katherine Hoadley; Henry L. Gómez; Fernando Moreno; María Del Monte-Millan; Iván Márquez-Rodas; Enrique Alvarez; Rocío Ramos-Medina; Javier Gayarre; Tatiana Massarrah; Inmaculada Ocaña; María Cebollero; Hugo Fuentes; Agusti Barnadas; Ana Isabel Ballesteros; Uriel Bohn; Charles M. Perou; Miguel Martin
Personalized Medicine and Imaging
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients
Britt I. Drögemöller; Beth Brooks; Carol Critchley; José G. Monzon; Galen E.B. Wright; Geoffrey Liu; Daniel J. Renouf; Christian K. Kollmannsberger; Philippe L. Bedard; Michael R. Hayden; Karen A. Gelmon; Bruce C. Carleton; Colin J.D. Ross
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Sarah B. Goldberg; Azeet Narayan; Adam J. Kole; Roy H. Decker; Jimmitti Teysir; Nicholas J. Carriero; Angela Lee; Roxanne Nemati; Sameer K. Nath; Shrikant M. Mane; Yanhong Deng; Nitin Sukumar; Daniel Zelterman; Daniel J. Boffa; Katerina Politi; Scott N. Gettinger; Lynn D. Wilson; Roy S. Herbst; Abhijit A. Patel
Author Choice
Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus
Alexa B. Schrock; Dean Pavlick; Samuel J. Klempner; Jon H. Chung; Brady Forcier; Allison Welsh; Lauren Young; Bryan Leyland-Jones; Rodolfo Bordoni; Richard D. Carvajal; Joseph Chao; Razelle Kurzrock; Jason K. Sicklick; Jeffrey S. Ross; Philip J. Stephens; Craig Devoe; Fadi Braiteh; Siraj M. Ali; Vincent A. Miller
Cancer Therapy: Preclinical
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function
Andrew Stiff; Prashant Trikha; Bethany Mundy-Bosse; Elizabeth McMichael; Thomas A. Mace; Brooke Benner; Kari Kendra; Amanda Campbell; Shalini Gautam; David Abood; Ian Landi; Vincent Hsu; Megan Duggan; Robert Wesolowski; Matthew Old; John Harrison Howard; Lianbo Yu; Nancy Stasik; Thomas Olencki; Natarajan Muthusamy; Susheela Tridandapani; John C. Byrd; Michael Caligiuri; William E. Carson
Author Choice
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto; Vindhya Udhane; David T. Hoang; Lei Gu; Vitali Alexeev; Kareem Malas; Karmel Cardenas; Jonathan R. Brody; Ulrich Rodeck; Carmen Bergom; Ken A. Iczkowski; Ken Jacobsohn; William See; Sara M. Schmitt; Marja T. Nevalainen
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
Jessica D. Lang; William P.D. Hendricks; Krystal A. Orlando; Hongwei Yin; Jeffrey Kiefer; Pilar Ramos; Ritin Sharma; Patrick Pirrotte; Elizabeth A. Raupach; Chris Sereduk; Nanyun Tang; Winnie S. Liang; Megan Washington; Salvatore J. Facista; Victoria L. Zismann; Emily M. Cousins; Michael B. Major; Yemin Wang; Anthony N. Karnezis; Aleksandar Sekulic; Ralf Hass; Barbara C. Vanderhyden; Praveen Nair; Bernard E. Weissman; David G. Huntsman; Jeffrey M. Trent
Biology of Human Tumors
Author Choice
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T. Chang; Alexander Penson; Neil B. Desai; Nicholas D. Socci; Ronglai Shen; Venkatraman E. Seshan; Ritika Kundra; Adam Abeshouse; Agnes Viale; Eugene K. Cha; Xueli Hao; Victor E. Reuter; Charles M. Rudin; Bernard H. Bochner; Jonathan E. Rosenberg; Dean F. Bajorin; Nikolaus Schultz; Michael F. Berger; Gopa Iyer; David B. Solit; Hikmat A. Al-Ahmadie; Barry S. Taylor
Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer
Rasmi R. Mishra; Nevin Belder; Suhail A. Ansari; Merve Kayhan; Hilal Bal; Umar Raza; Pelin G. Ersan; Ünal M. Tokat; Erol Eyüpoğlu; Özge Saatci; Pouria Jandaghi; Stefan Wiemann; Ayşegül Üner; Caglar Cekic; Yasser Riazalhosseini; Özgür Şahin
REGγ Controls Hippo Signaling and Reciprocal NF-κB–YAP Regulation to Promote Colon Cancer
Qingwei Wang; Xiao Gao; Tong Yu; Lei Yuan; Jie Dai; Weicang Wang; Geng Chen; Chan Jiao; Wang Zhou; Quan Huang; Long Cui; Pei Zhang; Robb E. Moses; Jianhua Yang; Fengyuan Chen; Junjiang Fu; Jianru Xiao; Lei Li; Yongyan Dang; Xiaotao Li
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds